225 related articles for article (PubMed ID: 30967497)
1. SNP rs2596542G>A in MICA is associated with risk of hepatocellular carcinoma: a meta-analysis.
Wang H; Cao H; Xu Z; Wang D; Zeng Y
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30967497
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis.
Luo X; Wang Y; Shen A; Deng H; Ye M
BMC Med Genet; 2019 Aug; 20(1):142. PubMed ID: 31419949
[TBL] [Abstract][Full Text] [Related]
3. Association between MICA rs2596542 Polymorphism with the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients.
Marangon CG; de Bitencorte JT; Michita RT; Lunge VR; Dos Santos DC; Álvares-da-Silva MR; Simon D
Pathol Oncol Res; 2020 Jul; 26(3):1519-1525. PubMed ID: 31471884
[TBL] [Abstract][Full Text] [Related]
4. Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma.
Lange CM; Bibert S; Dufour JF; Cellerai C; Cerny A; Heim MH; Kaiser L; Malinverni R; Müllhaupt B; Negro F; Semela D; Moradpour D; Kutalik Z; Bochud PY;
J Hepatol; 2013 Sep; 59(3):504-9. PubMed ID: 23665287
[TBL] [Abstract][Full Text] [Related]
5. Association Between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample.
Augello G; Balasus D; Fusilli C; Mazza T; Emma MR; Giannitrapani L; Agliastro R; Cervello M; Montalto G
OMICS; 2018 Apr; 22(4):274-282. PubMed ID: 29584564
[TBL] [Abstract][Full Text] [Related]
6. Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma.
Kumar V; Yi Lo PH; Sawai H; Kato N; Takahashi A; Deng Z; Urabe Y; Mbarek H; Tokunaga K; Tanaka Y; Sugiyama M; Mizokami M; Muroyama R; Tateishi R; Omata M; Koike K; Tanikawa C; Kamatani N; Kubo M; Nakamura Y; Matsuda K
PLoS One; 2012; 7(9):e44743. PubMed ID: 23024757
[TBL] [Abstract][Full Text] [Related]
7. Single nucleotide polymorphism of rs2596542 and the risk of hepatocellular carcinoma development: A meta-analysis.
Kuang XJ; Mo DC; Qin Y; Ahir BK; Wang JJ; Peng Z; Deng ZL
Medicine (Baltimore); 2019 Mar; 98(11):e14767. PubMed ID: 30882647
[TBL] [Abstract][Full Text] [Related]
8. Interaction Between Polymorphisms of IFN-γ and MICA Correlated with Hepatocellular Carcinoma.
Li H; Liu F; Zhu H; Zhou X; Lu J; Chang H; Hu J
Med Sci Monit; 2016 Feb; 22():549-53. PubMed ID: 26893439
[TBL] [Abstract][Full Text] [Related]
9. Genetic biomarkers for hepatocellular cancer risk in a caucasian population.
De Mattia E; Cecchin E; Polesel J; Bignucolo A; Roncato R; Lupo F; Crovatto M; Buonadonna A; Tiribelli C; Toffoli G
World J Gastroenterol; 2017 Sep; 23(36):6674-6684. PubMed ID: 29085212
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in MICA, but not in DEPDC5, HCP5 or PNPLA3, are associated with chronic hepatitis C-related hepatocellular carcinoma.
Hai H; Tamori A; Thuy LTT; Yoshida K; Hagihara A; Kawamura E; Uchida-Kobayashi S; Morikawa H; Enomoto M; Murakami Y; Kawada N
Sci Rep; 2017 Sep; 7(1):11912. PubMed ID: 28928439
[TBL] [Abstract][Full Text] [Related]
11. Identification of a functional variant in the MICA promoter which regulates MICA expression and increases HCV-related hepatocellular carcinoma risk.
Lo PH; Urabe Y; Kumar V; Tanikawa C; Koike K; Kato N; Miki D; Chayama K; Kubo M; Nakamura Y; Matsuda K
PLoS One; 2013; 8(4):e61279. PubMed ID: 23593449
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of C-reactive protein increase susceptibility to HBV-related hepatocellular carcinoma in a Guangxi male population.
Lao X; Ren S; Lu Y; Yang D; Qin X; Li S
Int J Clin Exp Pathol; 2015; 8(12):16055-63. PubMed ID: 26884882
[TBL] [Abstract][Full Text] [Related]
13. Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradication.
Huang CF; Wang SC; Yeh ML; Huang CI; Tsai PC; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Chen A; Yu ML
J Gastroenterol Hepatol; 2019 Jan; 34(1):249-255. PubMed ID: 29932235
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus-induced hepatocellular carcinoma: functional roles of MICA variants.
Tong HV; Toan NL; Song LH; Bock CT; Kremsner PG; Velavan TP
J Viral Hepat; 2013 Oct; 20(10):687-98. PubMed ID: 24010643
[TBL] [Abstract][Full Text] [Related]
15. Association of the GLB1 rs4678680 genetic variant with risk of HBV-related hepatocellular carcinoma.
Wang WT; Li Z; Shi M; Zhu H; Xiong X; Shang J; Liu J; Teng M; Yang M
Oncotarget; 2016 Aug; 7(35):56501-56507. PubMed ID: 27489354
[TBL] [Abstract][Full Text] [Related]
16. The influence of interleukin 28B polymorphisms on the risk of hepatocellular carcinoma among patients with HBV or HCV infection: An updated meta-analysis.
Qin S; Wang J; Zhou C; Xu Y; Zhang Y; Wang X; Wang S
Medicine (Baltimore); 2019 Sep; 98(38):e17275. PubMed ID: 31568008
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation at -1878 (rs2596542) in MICA gene region is associated with chronic hepatitis B virus infection in Saudi Arabian patients.
Al-Qahtani AA; Al-Anazi M; Abdo AA; Sanai FM; Al-Hamoudi W; Alswat KA; Al-Ashgar HI; Khalaf N; Viswan N; Al-Ahdal MN
Exp Mol Pathol; 2013 Dec; 95(3):255-8. PubMed ID: 23994040
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
[TBL] [Abstract][Full Text] [Related]
19. Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies.
Jiang G; Yu K; Shao L; Yu X; Hu C; Qian P; Xie H; Li J; Zheng J; Zheng S
BMC Cancer; 2015 Apr; 15():314. PubMed ID: 25927412
[TBL] [Abstract][Full Text] [Related]
20. Influence of interleukin-28B polymorphism on progression to hepatitis virus-induced hepatocellular carcinoma.
He J; Yu G; Li Z; Liang H
Tumour Biol; 2014 Sep; 35(9):8757-63. PubMed ID: 24874053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
